The European Commission said that Hungary has the right to approve the use of the Russian vaccine against coronavirus Sputnik V, but it will not be able to circulate in other EU countries, TASS reports.
In this case, Hungary itself will be responsible for the safety and effectiveness of the vaccine, and the European medical agency will have nothing to do with this.
Hungary became the first EU country to express interest in receiving the Russian Sputnik V vaccine. The effectiveness of the Russian vaccine, which is planned to be supplied to Hungary, is over 92%.
As we reported earlier, drugmaker Moderna has completed initial efficacy analysis of its Covid-19 vaccine from the drug's Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting Covid-19.
Moderna also found that it was 100% effective in preventing severe cases (such as those that would require hospitalization) and says it hasn't found any significant safety concerns during the trial. On the basis of these results, the company will file an application for emergency use authorization (EUA) with the U.S. Food and Drug Administration (FDA) on Monday.